| Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults MJM Bonten, SM Huijts, M Bolkenbaas, C Webber, S Patterson, S Gault, ... New England Journal of Medicine 372 (12), 1114-1125, 2015 | 1391 | 2015 |
| Antibiotic treatment strategies for community-acquired pneumonia in adults DF Postma, CH Van Werkhoven, LJR Van Elden, SFT Thijsen, ... New England Journal of Medicine 372 (14), 1312-1323, 2015 | 462 | 2015 |
| Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands MJJ Mangen, MH Rozenbaum, SM Huijts, CH van Werkhoven, ... European Respiratory Journal 46 (5), 1407-1416, 2015 | 147 | 2015 |
| Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study SJ Moorlag, RC van Deuren, CH van Werkhoven, M Jaeger, P Debisarun, ... Cell Reports Medicine 1 (5), 2020 | 96 | 2020 |
| Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label, nationwide … FJ Smits, AC Henry, MG Besselink, OR Busch, CH van Eijck, M Arntz, ... The Lancet 399 (10338), 1867-1875, 2022 | 91 | 2022 |
| The impact of age on the efficacy of 13-valent pneumococcal conjugate vaccine in elderly CH van Werkhoven, SM Huijts, M Bolkenbaas, DE Grobbee, MJM Bonten Clinical Infectious Diseases 61 (12), 1835-1838, 2015 | 91 | 2015 |
| Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship P Nauclér, A Huttner, CH Van Werkhoven, M Singer, P Tattevin, S Einav, ... Clinical Microbiology and Infection 27 (2), 175-181, 2021 | 80 | 2021 |
| Post-hoc analysis of a randomized controlled trial: Diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderly SM Huijts, CH van Werkhoven, M Bolkenbaas, DE Grobbee, MJM Bonten Vaccine 35 (34), 4444-4449, 2017 | 73 | 2017 |
| A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands BD Gessner, Q Jiang, CH Van Werkhoven, HL Sings, C Webber, D Scott, ... Vaccine 37 (38), 5777-5787, 2019 | 63 | 2019 |
| Quality of life in community-dwelling Dutch elderly measured by EQ-5D-3L MJJ Mangen, M Bolkenbaas, SM Huijts, CH van Werkhoven, MJM Bonten, ... Health and quality of life outcomes 15, 1-6, 2017 | 61 | 2017 |
| Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group VA Schweitzer, CH van Werkhoven, JR Baño, J Bielicki, S Harbarth, ... Clinical Microbiology and Infection 26 (1), 41-50, 2020 | 60 | 2020 |
| The quality of studies evaluating antimicrobial stewardship interventions: a systematic review VA Schweitzer, I van Heijl, CH van Werkhoven, J Islam, ... Clinical Microbiology and Infection 25 (5), 555-561, 2019 | 60 | 2019 |
| Impact of complications after pancreatoduodenectomy on mortality, organ failure, hospital stay, and readmission: analysis of a nationwide audit FJ Smits, ME Verweij, LA Daamen, CH van Werkhoven, L Goense, ... Annals of surgery 275 (1), e222-e228, 2022 | 59 | 2022 |
| Microbiota-based markers predictive of development of Clostridioides difficile infection M Berkell, M Mysara, BB Xavier, CH van Werkhoven, P Monsieurs, ... Nature communications 12 (1), 2241, 2021 | 57 | 2021 |
| Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the … T Ten Doesschate, SJ Moorlag, TW van der Vaart, E Taks, P Debisarun, ... Trials 21, 1-2, 2020 | 49 | 2020 |
| Efficacy of BCG vaccination against respiratory tract infections in older adults during the coronavirus disease 2019 pandemic SJ Moorlag, E Taks, T Ten Doesschate, TW van der Vaart, AB Janssen, ... Clinical Infectious Diseases 75 (1), e938-e946, 2022 | 48 | 2022 |
| Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial DF Postma, C Spitoni, CH Van Werkhoven, LJR Van Elden, ... BMC infectious diseases 19, 1-12, 2019 | 45 | 2019 |
| Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial T Ten Doesschate, TW van der Vaart, PA Debisarun, E Taks, SJ Moorlag, ... Clinical Microbiology and Infection 28 (9), 1278-1285, 2022 | 41 | 2022 |
| Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly CH van Werkhoven, RC Hollingsworth, SM Huijts, M Bolkenbaas, ... Vaccine 34 (28), 3275-3282, 2016 | 41 | 2016 |
| The immunomodulatory effects of statins in community-acquired pneumonia: a systematic review DPR Troeman, DF Postma, CH van Werkhoven, JJ Oosterheert Journal of Infection 67 (2), 93-101, 2013 | 41 | 2013 |
